177 related articles for article (PubMed ID: 16849628)
1. Hepatic glucose production is more sensitive to insulin-mediated inhibition than hepatic VLDL-triglyceride production.
den Boer MA; Voshol PJ; Kuipers F; Romijn JA; Havekes LM
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1360-4. PubMed ID: 16849628
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
3. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F
Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 treatment reduces endogenous insulin resistance via activation of central GLP-1 receptors in mice fed a high-fat diet.
Parlevliet ET; de Leeuw van Weenen JE; Romijn JA; Pijl H
Am J Physiol Endocrinol Metab; 2010 Aug; 299(2):E318-24. PubMed ID: 20530733
[TBL] [Abstract][Full Text] [Related]
5. Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration.
Vogelberg KH; Gries FA; Moschinski D
Horm Metab Res; 1980 Dec; 12(12):688-94. PubMed ID: 7009368
[TBL] [Abstract][Full Text] [Related]
6. FK-614, a selective peroxisome proliferator-activated receptor gamma agonist, improves peripheral glucose utilization while decreasing hepatic insulin extraction in alloxan-induced diabetic dogs.
Uchino H; Kim T; Lam TK; Yoshii H; Klement P; Williams W; Kawamori R; Giacca A
Metabolism; 2005 Sep; 54(9):1250-8. PubMed ID: 16125538
[TBL] [Abstract][Full Text] [Related]
7. Hepatic triglyceride contents are genetically determined in mice: results of a strain survey.
Lin X; Yue P; Chen Z; Schonfeld G
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1179-89. PubMed ID: 15591160
[TBL] [Abstract][Full Text] [Related]
8. Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans.
Lewis GF; Uffelman KD; Szeto LW; Weller B; Steiner G
J Clin Invest; 1995 Jan; 95(1):158-66. PubMed ID: 7814610
[TBL] [Abstract][Full Text] [Related]
9. S26948, a new specific peroxisome proliferator activated receptor gamma modulator improved in vivo hepatic insulin sensitivity in 48 h lipid infused rats.
Sohn KA; Cruciani-Guglielmacci C; Kassis N; Clément L; Ouali F; Caüzac M; Lebègue N; Berthelot P; Caignard DH; Pégorier JP; Renard P; Dacquet C; Ktorza A; Magnan C;
Eur J Pharmacol; 2009 Apr; 608(1-3):104-11. PubMed ID: 19250932
[TBL] [Abstract][Full Text] [Related]
10. Estimated liver weight is directly related to hepatic very low-density lipoprotein-triglyceride secretion rate in men.
Tsekouras YE; Magkos F; Kavouras SA; Panagiotakos DB; Sidossis LS
Eur J Clin Invest; 2008 Sep; 38(9):656-62. PubMed ID: 18837742
[TBL] [Abstract][Full Text] [Related]
11. Increased hepatic insulin sensitivity together with decreased hepatic triglyceride stores in hormone-sensitive lipase-deficient mice.
Voshol PJ; Haemmerle G; Ouwens DM; Zimmermann R; Zechner R; Teusink B; Maassen JA; Havekes LM; Romijn JA
Endocrinology; 2003 Aug; 144(8):3456-62. PubMed ID: 12865325
[TBL] [Abstract][Full Text] [Related]
12. The contribution of splanchnic fat to VLDL triglyceride is greater in insulin-resistant than insulin-sensitive men and women: studies in the postprandial state.
Hodson L; Bickerton AS; McQuaid SE; Roberts R; Karpe F; Frayn KN; Fielding BA
Diabetes; 2007 Oct; 56(10):2433-41. PubMed ID: 17601988
[TBL] [Abstract][Full Text] [Related]
13. CNTO736, a novel glucagon-like peptide-1 receptor agonist, ameliorates insulin resistance and inhibits very low-density lipoprotein production in high-fat-fed mice.
Parlevliet ET; Schröder-van der Elst JP; Corssmit EP; Picha K; O'Neil K; Stojanovic-Susulic V; Ort T; Havekes LM; Romijn JA; Pijl H
J Pharmacol Exp Ther; 2009 Jan; 328(1):240-8. PubMed ID: 18849357
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of pioglitazone and metformin on hepatic and extra-hepatic insulin action in people with type 2 diabetes.
Basu R; Shah P; Basu A; Norby B; Dicke B; Chandramouli V; Cohen O; Landau BR; Rizza RA
Diabetes; 2008 Jan; 57(1):24-31. PubMed ID: 17914032
[TBL] [Abstract][Full Text] [Related]
15. Determinants of VLDL-triglycerides production.
Nielsen S; Karpe F
Curr Opin Lipidol; 2012 Aug; 23(4):321-6. PubMed ID: 22617755
[TBL] [Abstract][Full Text] [Related]
16. Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux.
Yoshii H; Lam TK; Gupta N; Goh T; Haber CA; Uchino H; Kim TT; Chong VZ; Shah K; Fantus IG; Mari A; Kawamori R; Giacca A
Am J Physiol Endocrinol Metab; 2006 Jun; 290(6):E1089-97. PubMed ID: 16390863
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vivo plasma insulin levels on the relationship between perfusate free fatty acid concentration and triglyceride secretion by perfused rat livers.
Reaven GM; Mondon CE
Horm Metab Res; 1984 May; 16(5):230-2. PubMed ID: 6376309
[TBL] [Abstract][Full Text] [Related]
18. VLDL-triglyceride kinetics during hyperglycemia-hyperinsulinemia: effects of sex and obesity.
Mittendorfer B; Patterson BW; Klein S; Sidossis LS
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E708-15. PubMed ID: 12475756
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
Qin B; Anderson RA; Adeli K
Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
[TBL] [Abstract][Full Text] [Related]
20. Rhaponticin from rhubarb rhizomes alleviates liver steatosis and improves blood glucose and lipid profiles in KK/Ay diabetic mice.
Chen J; Ma M; Lu Y; Wang L; Wu C; Duan H
Planta Med; 2009 Apr; 75(5):472-7. PubMed ID: 19235684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
